of sympathetic and embryonic sensory neurons (Bueker, 1948; Levi-Montalcini & Hamburger, 1953) . It is active in civo, in embryonic chicks and neonatal rodents, and can be assayed in tissue culture by its effects on explants of sensory ganglia from chick embryos or, indeed, on sympathetic neurons from neonatal rodents either as explants or as dispersed cells. N G F activity is present in all snake venoms and, most importantly, in the submandibular glands of adult male mice. The early work has been well reviewed by LeviMontalcini & Angeletti (1968) and some of the more recent work by Levi-Montalcini & Aloe (1983) and by Thoenen & Barde (1980) . No attempt is made here to give a comprehensive account of the large amount of work carried out by many different laboratories on this, the first well-authenticated growth factor, but a number of serious difficulties and enigmas in the area will be considered.
The first relates to the distribution of N G F activity. The relation between the three sources named, i.e. mouse sarcomas, snake venoms and male mouse submandibular glands, is hard to understand. The factor has been purified from mouse salivary glands and characterized as a protein, called fl-NGF, with 118 amino acid residues. It is of known Abbreviation: NGF, Nerve Growth Factor. sequence (Angeletti & Bradshaw, 1971) . The factors from snake venoms vary in the degree of similarity to the mouse NGF, those from Naja naja and Crotalus adamenteus being quite similar, whereas those from Russell's viper and a number of other sources vary in size, PI and carbohydrate content (Pearce et al., 1972; Bailey et al., 1975; HogueAngeletti etal., 1976; Perez-Poloetal., 1978) . The factor has not been purified from mouse sarcomas. It is the amount of N G F present in salivary glands and snake venoms that renders the isolation feasible. In the former, N G F represents approx. 2% of the soluble protein in some strains, and in the latter, although there is considerably less than in mouse salivary glands, the factor can be isolated, though with some difficulty. The occurrence of such large quantities of N G F in male mouse salivary glands and in snake venoms is curious. Furthermore, other widely distributed and rich sources have been identified in recent years, including human term placenta (Goldstein et al., 1978) , guinea-pig prostate (Harper et al., 1979) , and bovine seminal plasma and seminal vesicles (Harper & Thoenen, 1980) . Purifications from some of these tissues have been reported (see Table I ). The mammalian factors appear to be more closely related to each other than are the snake factors to mouse NGF, as judged by behaviour on purification and sequence where known. However, the significance of the distribution is unknown. What is more, because the bioassay for N G F is very sensitive, detecting amounts in the order of 10-1 pg/l, other minor sources of N G F have been established (see Levi-Montalcini & Aloe, 1983; Thoenen & Burke, 1980) . Of these, mammalian sera are the most Vol. 12 relevant for the present adkcre. The amounts are included in Table 1 , which summarizes the relevant data on the quantities of NGF present in different sources. The serum concentrations are so low that purification of these NGFs would be quite impractical (Banks et al., 1973) . NGF is also produced by a number of tissues under culture conditions, though freshly excised samples of the same tissues do not contain NGF activity (Harper et al., 1976) .
The forms of NGF that have so far been purified from both mammalian sources and snake venoms are equipotent in tissue culture at concentrations of lO-lpg/l, whether assayed on chick sensory or neonatal-rodent sympatheticganglion explants. They are very much less active in neonatal rodents, with the snake NGFs being somewhat less effective than NGFs from mammalian sources .
In order to demonstrate effects in neonatal rodents or on rats in utero (Aloe & Levi-Montalcini, 1979) , NGF is given in daily doses in the order of mg/kg body wt. Many possible explanations of the decreased effectiveness in vivo could be advanced, such as difficulty of access to the site of action, or neutralization or destruction en route, but the difference in effectiveness in culture and in the newborn has not so far been commented on, much less explained. Certainly exogenous NGF is administered at far higher concentrations than those found in the serum of mammals so far tested, though it remains possible that neonatal serum concentrations are higher than those found in adults.
All NGFs so far isolated are antigenic, and antiserum to crude mouse salivary-gland NGF was produced more than 20 years ago (Levi-Montalcini & Booker, 1960) . Such antisera were shown to inhibit the development of the sympathetic nervous system in neonatal mice, and it has been said (Thoenen & Barde, 1980) that the occurrence of 'immunosympathectomy' on treatment with antiserum is the best evidence that NGF does, in fact, have a physiological role. However, although the NGFs from different sources are qualitatively indistinguishable, in culture and in neonatal rodents, the actions of the antisera are strikingly different. Antisera to snake NGFs do not cause immunosympathectomy (Banks et ol., 1978), though the antiserum to the guinea-pig factor does (Carstairs, 1980) . This may not be too surprising, since the mouse antiserum appears to act by neutralizing endogenous NGF rather than acting directly on target neurons by some lytic process [Banks et al. (1978) ; Ennis et al. (1979) ; findings later confirmed by Goedert et al. (1980) l. Antisera to snake NGFs show no cross-reactivity with pure mouse salivary-gland NGF, nor does the antiserum to mouse NGF neutralize NGFs from snake venoms (Bailey et al., 1976) , and it has been consistently shown that snake venom NGF is still active in mice that are treated concurrently with antisera to mouse NGF. However, there are other difficulties in understanding the immunological properties of NGFs from different sources, as indicated by reference to Table 2 . It was first reported more than 10 years ago (Banks et ol., 1972) that the antiserum to mouse salivary-gland NGF does not block the NGF activity that is found in mammalian sera, though it does block the NGFs produced by various mouse tissues in culture . Antisera to snake venom NGFs, on the other hand, do neutralize serum factors, the degree of cross-reaction being extensive (Banks et al., 1973) (cross-reactivity assessed by inhibition of biological activity in culture). More recently, evidence has been presented that human placental NGF does not cross-react with antiserum to mouse NGF (Walker, 1980; Beck & Perez-Polo, 1982) .
Questions immediately arise as to whether antiserum to human placental NGF is capable of causing immunosympathectomy in mice and whether the antisera to snake NGFs will neutralize human placental NGF as they do the mammalian serum factors. What the function of serum NGFs may be and what relation the mouse serum factor 3 Partly purified.
bears to the mouse salivary-gland factor is open to inquiry. Enough has been said of some of the striking characteristics of the immunological relations between NGFs from different sources to cast serious doubts on the validity of radioimmunoassay as a method of estimating NGF (Walker et al., 1980; Beck & Perez-Polo, 1982) . Unless homologous antisera are used (i.e. homologous with respect to source as well as species), ambiguous results may arise.
It was reported some years ago that NGF could be partly degraded by CNBr cleavage and tryptic hydrolysis to an active fragment containing only 30 amino acid residues (Mercanti et al., 1977) . We have reproduced some of the reported results and are continuing with the investigation, since other evidence also points to the existence of active fragments of the native P-form of the salivary-gland factor.
In particular, it has been demonstrated (Khan et al., 1983) that cells that are responsive to NGF in culture (but not non-responsive cells) are capable of releasing NGF activity into free solution from Sepharose beads to which /?-NGF had been covalently bound. The active form so released is unlikely to be identical with that originally linked to the support, and it is therefore possible that the form in which NGF is active either in culture or in vivo is not the form isolated from the few rich sources. This possibility affords an alternative explanation of the observations reported by Heumann et al. (1981) on the lack of effect of artificially internalized P-NGF on PC12 cells that normally respond to external NGF by producing fibres. It is unfortunately not yet known whether any or all antisera to NGFs neutralize the activity released by responsive cells from NGF coupled to Sepharose beads. The fragment produced by the method of Mercanti et al. (1977) is blocked by antiserum to mouse NGF (C. Springer, personal communication), but the material is unstable and has not been isolated in sufficient quantity to study in oivo. The characteristics of the distribution, potency, immunology and identity of this biologically active form remain to be investigated further.
An unusual finding, originally by Jane A. Warner, working in our laboratories and made almost by accident, is that NGF from mouse salivary glands is more potent, on a weight basis, than any known anti-inflammatory agent in what is a very common screen for potential therapeutic agents, namely the carrageenin-induced hind-paw oedema test in rats. The accidental nature of this finding followed a report that P-NGF, in the presence of phosphatidylserine, releases histamine from rat peritoneal mast cells (Bruni et al., 1982) . We have shown that some agents that have this activity, namely the mast-cell degranulating peptide from bee venom (Peptide 401) and the synthetic histamine releaser, Compound 48/80, both suppress carrageenininduced oedema in rats (Banks et al., 1980) and have subsequently demonstrated that allergen challenge in sensitized rats, presumed to cause histamine release, also greatly decreases swelling in response to carrageenin injected into the foot pad (Banks et al., 1983) . It is not suggested that these are true anti-inflammatory effects, since histamine release is inflammatory, and both Peptide 401 and Compound 48/80 enhance carrageenin-induced oedema when injected subplantar with the irritant rather than subcutaneously, by which route these and allergens in sensitized animals have an apparent anti-inflammatory effect. The actions are best described by the term 'counterirritancy' (Atkinson & Hicks, 1975) . It is not know how counter-irritants work, and the question is not relevant to NGF because, like all true anti-inflammatory agents, NGF is effective whether administered systemically (subcutaneously) or locally. The above merely explains why we should ever have looked for an effect of NGF in the carrageenin oedema test.
Some of the results obtained are given in Table 3 . Activity is only found over a restricted dose range (up to 25pgIkg body wt.), which in itself suggests that the mechanism of action is of considerable interest. A summary is given in Table 4 of the effectiveness of a variety of agents in this test. On a weight basis, NGF is 10 times more active than the synthetic steroid dexamethasone, and 1000 times more active than the classic non-steroidal anti-inflammatory drug, indomethacin. On a molar basis the difference would be even greater. As stated above, it is equally effective given subcutaneously or subplantar with the carrageenin, so is not acting as a counter-irritant. It is also effective if given 1 h before the irritant, as are dexamethasone and indomethacin. Over the years since the discovery of NGF, a number of erroneous claims have been made about the presence of NGF in different tissues, and particularly in the circulation in disease conditions and on sialectomy. Most of the mistakes have been due to failure to remove immunogenic contaminants before the development of radioimmunoassays (see Carstairs et al., 1977), but in one case (Perkins et al., 1979 ) the contaminant present in NGF was found to be a renin-like enzyme (Avrith et al., 1980) . It had been claimed by Avrith et al. (1980) that NGF had a dipsogenic effect on intracranial injection into rats, but this was subse- Table 3 . Effects of different doses of NGF on the swelling induced by carrageenin on subplantar injection in rats Groups of five male Sprague-Dawley rats weighing 145-155g were randomly caged. ,Hind-foot volumes were measured in a water-displacement plethysmometer (Ugo Basile) before injection, subplantar, of 0.1 ml of 1% carrageenin in saline (0.9% NaCl) into the right hind foot and, at the same time but subcutaneously, 0.1 ml of saline or the same volume of NGF in saline to give the above doses. Paw volumes were measured hourly for 5 h. All treatments were carried out blind. Significant difference from control group (Student's t-test): *P<O.Ol; **P<O.OOl. (%I quently shown to be due to the production of angiotensin by the action of the contaminating specific proteinase. Although N G F is extremely active in the carrageenininduced-oedema test, the possibility of renin contamination was considered, since the generation of angiotensin could, in principle, cause peripheral vasoconstriction and hence a decrease in swelling of the hind limb. N G F was purified from mouse salivary glands by the method of Chapman et al. (1979) and was immunogenically pure. A sample was given to Dr. J. T. Fitzsimons for intracranial injection into rats. He concluded that it contained no renin-like activity. In order to be doubly cautious, a sample of our N G F was treated with antiserum to pure mouse salivary-gland renin that had been raised in sheep, and kindly given by Professor K. Poulsen. This pretreatment did not alter the activity of the N G F in the carrageenin-induced-oedema test. On the other hand, preincubation with antiserum to mouse salivary-gland N G F totally abolished the anti-inflammatory activity. We are therefore encouraged to believe that these early observations indicate that NGF, at very low doses (1-5pg/kg body wt.), has anti-inflammatory activity in the carrageenin-induced-oedema test.
This finding is totally unexpected and requires a great deal of further investigation. We do not believe that it is a non-specific effect, since the doses required are low and because the effect is blocked by anti-NGF serum. Nor can it be mimicked by other proteins of similar size and basicity such as lysozyme, nor by phospholipase A*. It may be significant that the concentrations at which N G F is active in this test (l-5pg/kg) are comparable, given uniform distribution, with the concentrations found in mammalian sera (1-2pg/litre), whereas 1000 times more is needed to produce effects on the development of the nervous system in neonatal rats or mice. One is reminded of the situation found with epidermal growth factor, also from male mouse salivary glands, which was named because of its effects on keratinization of skin, premature opening of eyelids and eruption of incisors in mice, but was later shown to be the same as urogastrone, the polypeptide isolated with very great difficulty from human urine that has such potent effects on gastric acid secretion. The effect on epidermis in vivo is found at approx. 0.3mg/kg body wt. per day, but against acid secretion at 1 pg/kg (Gregory, 1975) . The effect of epidermal growth factor as a mitogen in culture is observed at the lower concentrations. So what is its true 'activity'?
It is also worth noting that there has long been in the literature on inflammation evidence that an anti-inflammatory substance, that may be protein in nature, is produced in response to injury (Billingham et al., 1969;  for review see Bonta, 1978) . Purification of this hypothetical substance has proved immensely difficult, as would be the case if one tried to purify N G F from mammalian sera. If N G F is a natural anti-inflammatory protein, its mode of action is likely to be quite distinct from those of the steroids and non-steroidal therapeutic agents. Since the latter particularly are used in large quantities for treating rheumatic and arthritic conditions, and all have undesirable side effects, a novel addition to the list of active anti-inflammatory drugs would be more than welcome.
